The new drug R&D and industrialization project of Taizhou Yiteng Jing'ang Pharmaceutical Co., Ltd. is settled in China Medical City
Updated:2018-07-12Hits:Word size:[ Large Medium Small ]

On the morning of July 10, China Medical City held a signing ceremony of the cooperation of the new drug R&D and industrialization project with Taizhou Yiteng Jing'ang Pharmaceutical Co., Ltd. Lu Chunyun, member of the Standing Committee of the CPC Taizhou Municipal Committee and Secretary of the Party Working Committee of Medicine High-Tech Zone, and Wu Yue, party member of  the Taizhou Municipal People's Government and Director of the Administrative Committee of Medicine High-tech Zone, attended the signing ceremony.


According to the cooperation agreement, the Yitang Jing'ang pharmaceutical industry will put four varieties of innovative medicines in China Medical City for industrialization. All these four varieties of medicines are the Category 1 new drugs in the country, and are approved by the Drug Clinical Trial Approval.


Lu Chunyun said that the China Medical City would continue to play the core advantage of professionalization, provide high - efficiency and high-quality services for the projects of Yiteng Jing'ang Pharmaceutical Co., Ltd., and make it a landmark enterprise in the park.





Print Close
Produced By 大汉网络 大汉版通发布系统